Literature DB >> 19931353

Tumor heterogeneity: causes and consequences.

Andriy Marusyk1, Kornelia Polyak.   

Abstract

With rare exceptions, spontaneous tumors originate from a single cell. Yet, at the time of clinical diagnosis, the majority of human tumors display startling heterogeneity in many morphological and physiological features, such as expression of cell surface receptors, proliferative and angiogenic potential. To a substantial extent, this heterogeneity might be attributed to morphological and epigenetic plasticity, but there is also strong evidence for the co-existence of genetically divergent tumor cell clones within tumors. In this perspective, we summarize the sources of intra-tumor phenotypic heterogeneity with emphasis on genetic heterogeneity. We review experimental evidence for the existence of both intra-tumor clonal heterogeneity as well as frequent evolutionary divergence between primary tumors and metastatic outgrowths. Furthermore, we discuss potential biological and clinical implications of intra-tumor clonal heterogeneity. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19931353      PMCID: PMC2814927          DOI: 10.1016/j.bbcan.2009.11.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  145 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Allelic imbalance in the clonal evolution of prostate carcinoma.

Authors:  L Cheng; D G Bostwick; G Li; Q Wang; N Hu; A O Vortmeyer; Z Zhuang
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

3.  Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.

Authors:  H Fujii; M Yoshida; Z X Gong; T Matsumoto; Y Hamano; M Fukunaga; R H Hruban; E Gabrielson; T Shirai
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

4.  Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.

Authors:  H Bissig; J Richter; R Desper; V Meier; P Schraml; A A Schäffer; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 5.  The influence of the microenvironment on the malignant phenotype.

Authors:  C C Park; M J Bissell; M H Barcellos-Hoff
Journal:  Mol Med Today       Date:  2000-08

6.  Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells.

Authors:  C A Klein; O Schmidt-Kittler; J A Schardt; K Pantel; M R Speicher; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 7.  Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.

Authors:  M W Lensch; R K Rathbun; S B Olson; G R Jones; G C Bagby
Journal:  Leukemia       Date:  1999-11       Impact factor: 11.528

8.  A growth-constrained environment drives tumor progression invivo.

Authors:  S Laconi; P Pani; S Pillai; D Pasciu; D S Sarma; E Laconi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

9.  Regional reproducibility of microsatellite instability in sporadic colorectal cancer.

Authors:  W S Samowitz; M L Slattery
Journal:  Genes Chromosomes Cancer       Date:  1999-10       Impact factor: 5.006

10.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells.

Authors:  B Mintz; K Illmensee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

View more
  580 in total

Review 1.  Histological types of breast cancer: how special are they?

Authors:  Britta Weigelt; Felipe C Geyer; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2010-04-18       Impact factor: 6.603

2.  The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

Authors:  Lauren L C Marotta; Vanessa Almendro; Andriy Marusyk; Michail Shipitsin; Janina Schemme; Sarah R Walker; Noga Bloushtain-Qimron; Jessica J Kim; Sibgat A Choudhury; Reo Maruyama; Zhenhua Wu; Mithat Gönen; Laura A Mulvey; Marina O Bessarabova; Sung Jin Huh; Serena J Silver; So Young Kim; So Yeon Park; Hee Eun Lee; Karen S Anderson; Andrea L Richardson; Tatiana Nikolskaya; Yuri Nikolsky; X Shirley Liu; David E Root; William C Hahn; David A Frank; Kornelia Polyak
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

3.  Tracing the tumor lineage.

Authors:  Nicholas E Navin; James Hicks
Journal:  Mol Oncol       Date:  2010-05-05       Impact factor: 6.603

Review 4.  Metronomic chemotherapy: new rationale for new directions.

Authors:  Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2010-06-08       Impact factor: 66.675

Review 5.  Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.

Authors:  Himadri Patel; Pritish Nilendu; Devashree Jahagirdar; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cancer Biol Ther       Date:  2017-12-08       Impact factor: 4.742

6.  Chemotherapeutic dosing implicated by pharmacodynamic modeling of in vitro cytotoxic data: a case study of paclitaxel.

Authors:  Hua He; Yanguang Cao
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-08-31       Impact factor: 2.745

7.  A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?

Authors:  Alireza Mirzaei; Gholamreza Tavoosidana; Afshin Abdi Rad; Farhad Rezaei; Masoumeh Tavakoli-Yaraki; Azade Amini Kadijani; Ehsan Khalili; Zahra Madjd
Journal:  Tumour Biol       Date:  2015-09-17

8.  A Fluorescence-Activated Single-Droplet Dispenser for High Accuracy Single-Droplet and Single-Cell Sorting and Dispensing.

Authors:  Yuling Qin; Li Wu; Jingang Wang; Rui Han; Jingyu Shen; Jiasi Wang; Shihan Xu; Amy L Paguirigan; Jordan L Smith; Jerald P Radich; Daniel T Chiu
Journal:  Anal Chem       Date:  2019-05-09       Impact factor: 6.986

9.  Challenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10.

Authors:  Matthew J Oborski; Charles M Laymon; Yongxian Qian; Frank S Lieberman; Arden D Nelson; James M Mountz
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

10.  Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model.

Authors:  Shawn P Carey; Alina Starchenko; Alexandra L McGregor; Cynthia A Reinhart-King
Journal:  Clin Exp Metastasis       Date:  2013-01-18       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.